AAAAAA

   
Results: 1-17 |
Results: 17

Authors: Ronckers, CM Land, CE Verduijn, PG Hayes, RB Stovall, M van Leeuwen, FE
Citation: Cm. Ronckers et al., Cancer mortality after nasopharyngeal radium irradiation in the Netherlands: a cohort study, J NAT CANC, 93(13), 2001, pp. 1021-1027

Authors: Noorda, EM Somers, R van Leeuwen, FE Vulsma, T Behrendt, H
Citation: Em. Noorda et al., Adult height and age at menarche in childhood cancer survivors, EUR J CANC, 37(5), 2001, pp. 605-612

Authors: Klip, H Burger, CW de Kraker, J van Leeuwen, FE
Citation: H. Klip et al., Risk of cancer in the offspring of women who underwent ovarian stimulationfor IVF, HUM REPR, 16(11), 2001, pp. 2451-2458

Authors: van Leeuwen, FE Bergman, L Beelen, MLR Gallee, MPW Hollema, H
Citation: Fe. Van Leeuwen et al., Tamoxifen and risk of endometrial cancer - Reply, LANCET, 357(9249), 2001, pp. 67-67

Authors: Verloop, J Rookus, MA van der Kooy, K van Leeuwen, FE
Citation: J. Verloop et al., Physical activity and breast cancer risk in women aged 20-54 years, J NAT CANC, 92(2), 2000, pp. 128-135

Authors: Travis, LB Andersson, M Gospodarowicz, M van Leeuwen, FE Bergfeldt, K Lynch, CF Curtis, RE Kohler, BA Wiklund, T Storm, H Holowaty, E Hall, P Pukkala, E Sleijfer, DT Clarke, EA Boice, JD Stovall, M Gilbert, E
Citation: Lb. Travis et al., Treatment-associated leukemia following testicular cancer, J NAT CANC, 92(14), 2000, pp. 1165-1171

Authors: Klip, H Burger, CW Kenemans, P van Leeuwen, FE
Citation: H. Klip et al., Cancer risk associated with subfertility and ovulation induction: a review, CANC CAUSE, 11(4), 2000, pp. 319-344

Authors: Broeks, A Russell, NS Floore, AN Urbanus, JHM Dahler, EC van't Veer, MB Hagenbeek, A Noordijk, EM Crommelin, MA van Leeuwen, FE van't Veer, LJ
Citation: A. Broeks et al., Increased risk of breast cancer following irradiation for Hodgkin's disease is not a result of ATM germline mutations, INT J RAD B, 76(5), 2000, pp. 693-698

Authors: van Leeuwen, FE Klokman, WJ van't Veer, MB Hagenbeek, A Krol, ADG Vetter, UAO Schaapveld, M van Heerde, P Burgers, JMV Somers, R Aleman, BMP
Citation: Fe. Van Leeuwen et al., Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood, J CL ONCOL, 18(3), 2000, pp. 487-497

Authors: Metayer, C Lynch, CF Clarke, EA Glimelius, B Storm, H Pukkala, E Joensuu, T van Leeuwen, FE van't Veer, MB Curtis, RE Holowaty, EJ Andersson, M Wiklund, T Gospodarowicz, M Travis, LB
Citation: C. Metayer et al., Second cancers among long-term survivors of Hodgkin's disease diagnosed inchildhood and adolescence, J CL ONCOL, 18(12), 2000, pp. 2435-2443

Authors: van Leeuwen, FE Klokman, WJ Aleman, BMP
Citation: Fe. Van Leeuwen et al., Second malignancies in Hodgkin's disease - Reply, J CL ONCOL, 18(10), 2000, pp. 2186-2187

Authors: Bergman, L Beelen, MLR Gallee, MPW Hollema, H Benraadt, J van Leeuwen, FE
Citation: L. Bergman et al., Risk and prognosis of endometrial cancer after tamoxifen for breast cancer, LANCET, 356(9233), 2000, pp. 881-887

Authors: Verloop, J Rookus, MA van Leeuwen, FE
Citation: J. Verloop et al., Prevalence of gynecologic cancer in women exposed to diethylstilbestrol inutero., N ENG J MED, 342(24), 2000, pp. 1838-1839

Authors: Broeks, A Urbanus, JHM Floore, AN Dahler, EC Klijn, JGM Rutgers, EJT Devilee, P Russell, NS van Leeuwen, FE van't Veer, LJ
Citation: A. Broeks et al., ATM-heterozygous germline mutations contribute to breast cancer-susceptibility, AM J HU GEN, 66(2), 2000, pp. 494-500

Authors: Burger, CW van Leeuwen, FE Scheele, F Kenemans, P
Citation: Cw. Burger et al., Hormone replacement therapy in women treated for gynaecological malignancy, MATURITAS, 32(2), 1999, pp. 69-76

Authors: Vander Poorten, VLM Balm, AJM Hilgers, FJM Tan, IB Loftus-Coll, BM Keus, RB van Leeuwen, FE Hart, AAM
Citation: Vlm. Vander Poorten et al., The development of a prognostic score for patients with parotid carcinoma, CANCER, 85(9), 1999, pp. 2057-2067

Authors: van Leeuwen, FE Swerdlow, AJ Valagussa, P Tucker, MA
Citation: Fe. Van Leeuwen et al., Second cancers after treatment of Hodgkin's disease, HODGKIN'S DISEASE, 1999, pp. 607-632
Risultati: 1-17 |